GEODE CAPITAL MANAGEMENT, LLC
Position in ANEB — Anebulo Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in ANEB
as of Dec 31, 2025
· filed Feb 9, 2026
Position Value
$162,367
-$272,902 QoQ
Shares Held
160,760
-7.7% QoQ
Ownership
0.394%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 19 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANEB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in ANEB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $162,367 | 160,760 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $435,269 | 174,108 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $296,236 | 205,720 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $267,043 | 205,418 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $153,452 | 91,341 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $169,434 | 87,790 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $140,070 | 51,308 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $65,369 | 22,777 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||